| scholarly article | Q13442814 |
| P2093 | author name string | Lui KJ | |
| Kendal AP | |||
| P2860 | cites work | Natural history of influenza type A in the United States, 1957-1972. | Q39323722 |
| Serious morbidity and mortality associated with influenza epidemics | Q40246988 | ||
| An evaluation of influenza mortality surveillance, 1962-1979. I. Time series forecasts of expected pneumonia and influenza deaths | Q41473024 | ||
| William Farr: founder of modern concepts of surveillance | Q41861079 | ||
| Mortality during influenza epidemics in the United States, 1967-1978. | Q53761632 | ||
| "A study of excess mortality during influenza epidemics in the United States, 1968-1976" | Q70301697 | ||
| Underestimation of the role of pneumonia and influenza in causing excess mortality | Q70783014 | ||
| Public Health Weekly Reports for AUGUST 15, 1919 | Q83538822 | ||
| Public Health Weekly Reports for AUGUST 14, 1931 | Q83540937 | ||
| Public Health Weekly Reports for NOVEMBER 11, 1932 | Q83541207 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | United States of America | Q30 |
| P304 | page(s) | 712-716 | |
| P577 | publication date | 1987-06-01 | |
| P1433 | published in | American Journal of Public Health | Q4744266 |
| P1476 | title | Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985. | |
| P478 | volume | 77 |
| Q49084262 | "McFlu". The Monroe County, New York, Medicare vaccine demonstration |
| Q30354406 | 1951 influenza epidemic, England and Wales, Canada, and the United States. |
| Q51510333 | A compelling rationale for using preoperative visits to complete adult immunizations. |
| Q67841313 | A new influenza surveillance system in France: The Ile-De-France ?GROG?. 2. Validity of indicators (1984?1989) |
| Q41327152 | A new influenza surveillance system in France: the Ile-de-France "GROG". 1. Principles and methodology |
| Q47257686 | A performance-based incentive program for influenza immunization in the elderly. |
| Q36460988 | ActiveGuidelines: integrating Web-based guidelines with computer-based patient records. |
| Q45100390 | Adult immunizations: are they worth the trouble? |
| Q45164155 | Adverse effects of amantadine and oseltamivir used during respiratory outbreaks in a center for developmentally disabled adults |
| Q38512805 | Air pollution, lagged effects of temperature, and mortality: The Netherlands 1979-87 |
| Q43177107 | Antibody response to influenza vaccination in nursing home residents and healthcare workers during four successive seasons in Niigata, Japan |
| Q37119746 | Application of Directigen FLU-A for the detection of influenza A virus in human and nonhuman specimens |
| Q44604102 | Are the 2-isomers of the drug rimantadine active anti-influenza A agents? |
| Q36699442 | Attenuation of influenza A virus by insertion of a foreign epitope into the neuraminidase |
| Q31166045 | Clinical data on Fluarix: an inactivated split seasonal influenza vaccine |
| Q30222083 | Clinical vaccine development for H5N1 influenza |
| Q45063816 | Communitywide laboratory-based influenza surveillance focused on older persons, 1989-1992. |
| Q40211364 | Comparison of Directigen FLU-A with viral isolation and direct immunofluorescence for the rapid detection and identification of influenza A virus |
| Q37069720 | Comparison of rapid detection methods for influenza A virus and their value in health-care management of institutionalized geriatric patients. |
| Q36972930 | Current Recommendations for the Prevention and Treatment of Influenza in the Older Population |
| Q28349496 | Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities |
| Q73835887 | Decreased pulmonary clearance of S. pneumoniae following influenza A infection in mice |
| Q48032303 | Design of the Dutch prevention of influenza, surveillance and management (PRISMA) study |
| Q44207170 | Design, synthesis, and neuraminidase inhibitory activity of GS-4071 analogues that utilize a novel hydrophobic paradigm |
| Q30353079 | Economics of neuraminidase inhibitor stock piling for pandemic influenza, Singapore |
| Q41149778 | Effectiveness of an anti-influenza vaccination program in 4 primary care centers |
| Q74617535 | Effectiveness of influenza vaccination in the elderly in a community in Italy |
| Q43209418 | Efficacy of influenza vaccine in the elderly: reduction in risks of mortality and morbidity during an influenza A (H3N2) epidemic for the elderly in nursing homes |
| Q35019832 | Elevated influenza-related excess mortality in South African elderly individuals, 1998-2005. |
| Q30150775 | Epidemiological evidence of an early wave of the 1918 influenza pandemic in New York City |
| Q83381407 | Epidemiology of influenza |
| Q37179273 | Estimates of US influenza-associated deaths made using four different methods |
| Q72654091 | Estimates of the US health impact of influenza |
| Q57110014 | Estimating influenza-associated deaths in the United States |
| Q40861655 | Evaluation of BioStar FLU OIA assay for rapid detection of influenza A and B viruses in respiratory specimens |
| Q72594135 | Evaluation of a simple office-based strategy for increasing influenza vaccine administration and the effect of differing reimbursement plans on the patient acceptance rate |
| Q36218344 | Exploring reasons for bed pressures in Winnipeg acute care hospitals |
| Q71156436 | Factors associated with influenza vaccination coverage among the elderly: role of health care personnel |
| Q44074936 | Five years of sentinel surveillance of acute respiratory infections (1985-1990): the benefits of an influenza early warning system |
| Q36407258 | Fluarix, inactivated split-virus influenza vaccine |
| Q40900611 | Future health scenarios as a tool in the surveillance of unintentional injuries |
| Q34292712 | Genetic characterization of seasonal influenza A (H3N2) viruses in Ontario during 2010-2011 influenza season: high prevalence of mutations at antigenic sites |
| Q38662482 | Heterogeneity in Estimates of the Impact of Influenza on Population Mortality: A Systematic Review. |
| Q51703374 | Hospitalizations and deaths due to respiratory illnesses during influenza seasons: a comparison of community residents, senior housing residents, and nursing home residents. |
| Q36110418 | Humoral and cellular immune responses to influenza vaccination in children with cancer receiving chemotherapy |
| Q39557208 | Identification of GS 4104 as an orally bioavailable prodrug of the influenza virus neuraminidase inhibitor GS 4071. |
| Q44534297 | Immunization against influenza in the elderly: the Argentinian experience, 1993-1997. |
| Q73865875 | Immunogenicity of trivalent subunit versus virosome-formulated influenza vaccines in geriatric patients |
| Q34006839 | Immunoglobulin A (IgA) responses and IgE-associated inflammation along the respiratory tract after mucosal but not systemic immunization |
| Q43152401 | Improving influenza immunization rates among healthcare workers caring for high-risk pediatric patients |
| Q50545902 | Improving influenza vaccination rates for high-risk inpatients |
| Q30428323 | Improving surveillance of the impact of influenza and its prevention in Canada |
| Q51200153 | Incidence of influenza-associated mortality and hospitalizations in Argentina during 2002-2009. |
| Q33809975 | Individual and community impact of influenza |
| Q57118369 | Influenza |
| Q106728879 | Influenza Recycling and Secular Trends in Mortality and Natality |
| Q34578278 | Influenza and current guidelines for its control |
| Q24814492 | Influenza associated excess mortality in Germany, 1985-2001. |
| Q35879214 | Influenza epidemics in the United States, France, and Australia, 1972-1997 |
| Q30383133 | Influenza excess mortality from 1950-2000 in tropical Singapore. |
| Q37161104 | Influenza in older adults: impact of vaccination of school children |
| Q30309203 | Influenza in the acute hospital setting |
| Q30366153 | Influenza infection and COPD. |
| Q33703065 | Influenza mortality among the elderly in France, 1980-90: how many deaths may have been avoided through vaccination? |
| Q36669155 | Influenza surveillance |
| Q43176441 | Influenza surveillance in Korea: establishment and first results of an epidemiological and virological surveillance scheme |
| Q50595577 | Influenza vaccination in older patients. Immunogenicity, epidemiology and available agents. |
| Q39552621 | Influenza vaccination levels and influenza-like illness in long-term-care facilities for elderly people in Niigata, Japan, during an influenza A (H3N2) epidemic |
| Q50778631 | Influenza vaccination of healthcare workers in the United States, 1989-2002. |
| Q44933275 | Influenza vaccination: a collaborative effort to improve the health of the community |
| Q34991460 | Influenza vaccinations: who needs them and when? |
| Q34189122 | Influenza vaccines: a review and rationale for use in developed and underdeveloped countries. |
| Q37275790 | Influenza virus neuraminidase contributes to secondary bacterial pneumonia |
| Q39627260 | Influenza--a controllable disease? |
| Q45172907 | Influenza-associated excess mortality in southern Brazil, 1980-2008. |
| Q57706328 | Influenza-attributable deaths, Canada 1990-1999 |
| Q56487569 | Influenza-related mortality in the Italian elderly: No decline associated with increasing vaccination coverage |
| Q34219687 | Influenza. Cost of illness and considerations in the economic evaluation of new and emerging therapies |
| Q33809986 | Influenza. The role of burden-of-illness research |
| Q30419059 | Influenza: global surveillance for epidemic and pandemic variants |
| Q35745677 | Intranasal cold-adapted influenza virus vaccine combined with inactivated influenza virus vaccines: an extra boost for the elderly? |
| Q42128915 | Intranasal immunization of ferrets with commercial trivalent influenza vaccines formulated in a nanoemulsion-based adjuvant |
| Q34324982 | Live attenuated influenza virus vaccines: new options for the prevention of influenza |
| Q34730017 | Long term persistence of IgE anti-influenza virus antibodies in pediatric and adult serum post vaccination with influenza virus vaccine |
| Q67594905 | Long-term success with the national health objective for influenza vaccination: an institution-wide model |
| Q39273037 | Measuring the effects of reminders for outpatient influenza immunizations at the point of clinical opportunity |
| Q45986318 | Meta-analysis of effectiveness of interventions to increase influenza immunization rates among high-risk population groups. |
| Q33703625 | Monitoring mortality as an indicator of influenza in Catalonia, Spain |
| Q30421831 | Mortality burden of the 2009 A/H1N1 influenza pandemic in France: comparison to seasonal influenza and the A/H3N2 pandemic |
| Q30333613 | New aspects of influenza viruses |
| Q94395660 | Normalisation et amélioration de la surveillance de la grippe: Mémorandum d'une réunion OMS/GEIG |
| Q43713806 | Novel 3-(2-adamantyl)pyrrolidines with potent activity against influenza A virus-identification of aminoadamantane derivatives bearing two pharmacophoric amine groups |
| Q33302688 | Online detection and quantification of epidemics |
| Q28379409 | Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infection |
| Q45421069 | Patterns of influenza-associated mortality among US elderly by geographic region and virus subtype, 1968-1998. |
| Q50679559 | Pneumococcal immunizations at flu clinics: the impact of community-wide outreach. |
| Q35160881 | Population-based hospitalization burden of influenza a virus subtypes and antigenic drift variants in children in Hong Kong (2004-2011). |
| Q80247315 | Predictors of influenza immunization among home care clients in Ontario |
| Q64128900 | Predictors of vaccination behavior among persons ages 65 years and older |
| Q43592384 | Prevalence of influenza immunisation in Australia and suggestions for future targeting of campaigns |
| Q40698548 | Prevention of community-acquired pneumonia. |
| Q47809619 | Rapid Tests for Influenza |
| Q33704652 | Reduction in hospital admissions for pneumonia in non-institutionalised elderly people as a result of influenza vaccination: a case-control study in Spain |
| Q37067517 | Revised estimates of influenza-associated excess mortality, United States, 1995 through 2005. |
| Q33845790 | Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly |
| Q30642719 | Spectral analysis based on fast Fourier transformation (FFT) of surveillance data: the case of scarlet fever in China. |
| Q36647895 | Structure-based organic synthesis of drug prototypes: a personal odyssey |
| Q55381852 | Surveillance de la grippe. |
| Q50595838 | The Effectiveness of Vaccination against Influenza in Healthy, Working Adults |
| Q59357667 | The Effects of Birth Year, Age and Sex on Hemagglutination Inhibition Antibody Responses to Influenza Vaccination |
| Q43546829 | The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine |
| Q44144691 | The effect of Syntex adjuvant formulation (SAF-m) on humoral immunity to the influenza virus in the mouse |
| Q33380394 | The effect of universal influenza immunization on mortality and health care use. |
| Q43209644 | The effectiveness of influenza vaccine against influenza a (H3N2) virus infections in nursing homes in Niigata, Japan, during the 1998-1999 and 1999-2000 seasons |
| Q33725066 | The global impact of influenza on morbidity and mortality |
| Q54731473 | The impact of influenza epidemics on mortality: introducing a severity index. |
| Q35065146 | The impact of influenza-associated respiratory illnesses on hospitalizations, physician visits, emergency room visits, and mortality. |
| Q51622179 | The impact of seasonal and year-round transmission regimes on the evolution of influenza A virus. |
| Q78805899 | The information network of senior citizens in Geneva, Switzerland, and progress in flu vaccination coverage between 1991 and 2000 |
| Q30322201 | The next influenza pandemic: lessons from Hong Kong, 1997 |
| Q44198764 | Time series methods for obtaining excess mortality attributable to influenza epidemics. |
| Q30362164 | Trends for influenza-related deaths during pandemic and epidemic seasons, Italy, 1969-2001 |
| Q37072968 | Use of PCR-enzyme immunoassay for identification of influenza A virus matrix RNA in clinical samples negative for cultivable virus |
| Q30801265 | Use of ambulance dispatch data as an early warning system for communitywide influenzalike illness, New York City. |
| Q43975411 | Use of oseltamivir during influenza outbreaks in Ontario nursing homes, 1999-2000. |
| Q40938295 | Utility of reverse transcriptase PCR for rapid diagnosis of influenza a virus infection and detection of amantadine-resistant influenza a virus isolates |
| Q30951120 | Vaccination of high-risk patients against influenza: impact on primary care contact rates during epidemics. Analysis of routinely collected data |
| Q77308210 | Validation of self-report of influenza and pneumococcal vaccination status in elderly outpatients |
| Q36460152 | Value of ICD-9 coded chief complaints for detection of epidemics. |
| Q46545833 | Value of ICD-9-Coded Chief Complaints for Detection of Epidemics. |
| Q58288463 | War-related excess mortality in The Netherlands, 1944–45: New estimates of famine- and non-famine-related deaths from national death records |
| Q70178635 | [Epidemiological surveillance of mortality based on burrial records] |
Search more.